To determine which cisplatin-induced shifts in carbon flux are generalizable we evaluated HN31, an established HNSCC cell line which is isogenic to HN30 with the exception of 2 TP53 mutations resulting in protein stabilization and loss of function (Fig. 7A inset; Supp. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.